Crespi CL - Search Results

1

Comparison of species differences of P-glycoproteins in beagle dog, rhesus monkey, and human using Atpase activity assays.

Xia CQ, Xiao G, Liu N, Pimprale S, Fox L, Patten CJ, Crespi CL, Miwa G, Gan LS. Xia CQ, et al. Among authors: crespi cl. Mol Pharm. 2006 Jan-Feb;3(1):78-86. doi: 10.1021/mp050034j. Mol Pharm. 2006. PMID: 16686372

2

A high-throughput screen to identify inhibitors of aromatase (CYP19).

Stresser DM, Turner SD, McNamara J, Stocker P, Miller VP, Crespi CL, Patten CJ. Stresser DM, et al. Among authors: crespi cl. Anal Biochem. 2000 Sep 10;284(2):427-30. doi: 10.1006/abio.2000.4729. Anal Biochem. 2000. PMID: 10964434 No abstract available.

3

Analysis of drug transport and metabolism in cell monolayer systems that have been modified by cytochrome P4503A4 cDNA-expression.

Crespi CL, Fox L, Stocker P, Hu M, Steimel DT. Crespi CL, et al. Eur J Pharm Sci. 2000 Nov;12(1):63-8. doi: 10.1016/s0928-0987(00)00141-x. Eur J Pharm Sci. 2000. PMID: 11121734

4

Potential role for P-glycoprotein in the non-proportional pharmacokinetics of UK-343,664 in man.

Abel S, Beaumont KC, Crespi CL, Eve MD, Fox L, Hyland R, Jones BC, Muirhead GJ, Smith DA, Venn RF, Walker DK. Abel S, et al. Among authors: crespi cl. Xenobiotica. 2001 Aug-Sep;31(8-9):665-76. doi: 10.1080/00498250110052779. Xenobiotica. 2001. PMID: 11569532

5

Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450.

Crespi CL, Miller VP, Penman BW. Crespi CL, et al. Anal Biochem. 1997 May 15;248(1):188-90. doi: 10.1006/abio.1997.2145. Anal Biochem. 1997. PMID: 9177742 No abstract available.

6

Fluorometric high-throughput screening for inhibitors of cytochrome P450.

Miller VP, Stresser DM, Blanchard AP, Turner S, Crespi CL. Miller VP, et al. Among authors: crespi cl. Ann N Y Acad Sci. 2000;919:26-32. doi: 10.1111/j.1749-6632.2000.tb06864.x. Ann N Y Acad Sci. 2000. PMID: 11083094

7

The use of heterologously expressed drug metabolizing enzymes--state of the art and prospects for the future.

Crespi CL, Miller VP. Crespi CL, et al. Pharmacol Ther. 1999 Nov;84(2):121-31. doi: 10.1016/s0163-7258(99)00028-5. Pharmacol Ther. 1999. PMID: 10596902 Review.

8

Substrate-dependent modulation of CYP3A4 catalytic activity: analysis of 27 test compounds with four fluorometric substrates.

Stresser DM, Blanchard AP, Turner SD, Erve JC, Dandeneau AA, Miller VP, Crespi CL. Stresser DM, et al. Among authors: crespi cl. Drug Metab Dispos. 2000 Dec;28(12):1440-8. Drug Metab Dispos. 2000. PMID: 11095581

9

Fluorometric screening for metabolism-based drug--drug interactions.

Crespi CL, Stresser DM. Crespi CL, et al. J Pharmacol Toxicol Methods. 2000 Jul-Aug;44(1):325-31. doi: 10.1016/s1056-8719(00)00112-x. J Pharmacol Toxicol Methods. 2000. PMID: 11274899

10

Cytochrome P450 fluorometric substrates: identification of isoform-selective probes for rat CYP2D2 and human CYP3A4.

Stresser DM, Turner SD, Blanchard AP, Miller VP, Crespi CL. Stresser DM, et al. Among authors: crespi cl. Drug Metab Dispos. 2002 Jul;30(7):845-52. doi: 10.1124/dmd.30.7.845. Drug Metab Dispos. 2002. PMID: 12065444

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters